Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ronald French

Hand Surgery Kenner, LA Medical Doctor

NPI 1700862448 CMS profile 981538

200 W Esplanade Ave, Suite 210, Kenner, LA 70065

Open in the dashboard

General payments

$1,497

45 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ronald French of Kenner, LA is reported in the CMS Open Payments database as having received $1,497 across 45 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 41st percentile of Hand Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $475 12
2024 General $606 16
2023 General $68 2
2022 General $57 3
2021 General $155 4
2020 General $99 6
2019 General $37 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ronald French
  • Hand Surgery median
  • Middle half of Hand Surgery
  • National median

In program year 2025, general payments to Ronald French were reported at $475. Among 1,842 Hand Surgery profiles paid that year, the median was $270 and the middle half received between $102 and $1,118.

Show as a table
Year Ronald French Hand Surgery median Middle half National median
2019 $37 $383 $106–$1,905 $163
2020 $99 $172 $51–$1,268 $114
2021 $155 $263 $71–$1,591 $132
2022 $57 $336 $87–$1,938 $149
2023 $68 $233 $81–$1,114 $160
2024 $606 $258 $88–$1,203 $164
2025 $475 $270 $102–$1,118 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $334 8 payments
  2. Acumed LLC $313 4 payments
  3. Smith+Nephew, Inc. $129 6 payments
  4. Horizon Therapeutics plc $118 8 payments
  5. Zimmer Biomet Holdings, Inc. $97 1 payment
  6. Siemens Medical Solutions USA, Inc. $66 1 payment
  7. Treace Medical Concepts, Inc. $63 2 payments
  8. Bioventus LLC $63 3 payments
  9. Alon Medical Technology $50 1 payment
  10. Kerecis Limited $36 1 payment
  11. Other $229 10 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $1,497 45 payments
Products named General payments · program years 2019–2025
  1. ACUMED Hand & Wrist $199 3 payments
  2. ACUMED Screw & Pin $199 3 payments
  3. VARIAX $146 1 payment
  4. CONEXTIONS TR TENDON REPAIR SYSTEM-IMPLANT MECHANISM $146 1 payment
  5. Hand Fracture System $114 1 payment
  6. Acu-Loc Wrist Plating System $114 1 payment
  7. Acutrak Headless Compression Screw System $114 1 payment
  8. PENNSAID $90 6 payments
  9. ACUSON Origin Diagnostic Ultrasound System $66 1 payment
  10. ACUSON Sequoia Diagnostic Ultrasound System $66 1 payment
  11. Other $1,184 45 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 16 drugs

Part D claims

1,072

Median for Hand Surgery: 118

Drug cost

$8,845

Median for Hand Surgery: $615

Branded share of claims

20.1%

Median for Hand Surgery: 34.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diclofenac Sodium Generic 102 $2,186
Celecoxib Generic 198 $2,087
Ibuprofen Generic 129 $953
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 139 $652
Sulindac Generic 50 $651
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 77 $515
Meloxicam Generic 139 $409
Tizanidine Hcl Generic 40 $242
Gabapentin Generic 47 $241
Minocycline Hcl Generic 18 $206

The 10 drugs with the highest cost, of 16 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,399 Part D prescribers listed as Hand Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 33 billing codes

Paid by Medicare

$39,308

Medicare's payments for the services billed

Medicare patients

150

Average age 71

Services billed

414

91 women, 59 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 65%
Diabetes 35%
Chronic kidney disease 31%
Depression 24%
Ischemic heart disease 21%
Heart failure 16%
COPD 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

45 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Hand Surgery in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record